KUNMING, China--(BUSINESS WIRE)--On July 8th, the 25th World Congress of Dermatology (WCD), referred to as the "Olympics of the Dermatology," concluded in Singapore, with the Chinese top dermatology skin care brand WINONA emerging as the focus of the conference.

At the conference, WINONA, in collaboration with domestic and international dermatology experts and scholars, discussed key issues and development trends related to skin health ecology, such as sensitive skin, Melasma, and atopic dermatitis. In addition to delivering Chinese brand image to the world, WINONA also jointly promoted the development of the broader skin health ecology alongside global brands.

At this WCD, Professor Philippe Humbert released the latest international observational results of WINONA products, reaffirming the effectiveness of two WINONA products including "WINONA Sensitiveness Relieving Moisturizing Tolerance-Extreme Cream".

Looking ahead, Botanee continues to move forward. During the WCD, Botanee Group, WINONA's parent company, simultaneously hosted the Botanee International Skin Health Summit 2023. For the first time, Botanee Group presented its four major brands - WINONA, WINONA Baby, AOXMED, and Beforteen - in a multi-brand layout, clearly indicating Botanee's second growth curve.

Introducing International Frontier Theory: The four-in-one Therapy Gains International Expert Recognition

Melasma treatment has long been a challenge in dermatology. Previous research focused solely on the mechanism of melanocyte activation leading to excessive pigment production, leaving a gap in the clinical availability of ideal skin-whitening and spot-removing agents. At this WCD, Professor He Li, leader of the Ministry of Education's Innovation Team and Executive Dean of Hospital of Dermatology of the First Affiliated Hospital of Kunming Medical University, shared a significant breakthrough that she and her team achieved in understanding the pathogenesis of melasma and precise intervention. From a mechanistic basis, the treatment of melasma Should pay attention to: Hyperpigmentation, Damaged skin barrier, Inflammatory Vascular, proliferation and Photoaging. Thus, targeting the four major pathogenisis of melasma, constituting a four-in-one mechanism.

Moreover, this mechanism - targeting the four major pathogenisis of melasma- has reached expert consensus and been published in the International Journal of Dermatology and Venereology. As a leading international theory, it was released to the global community in English and has gained recognition from international dermatology experts.

At the conference, based on the four-in-one mechanism skin-lightening mechanism, WINONA launched a new skin-whitening and spot-Correcting product - WINONA Camellia-Lucent Spot Correcting Essence. Studies have shown that skin whitening products containing PRINSEPIA UTILIS ROYLE and CAMELLIA RETICULATA extracts can significantly enhance therapeutic efficacy during the active and stable stages of melasma, which contains the effects of repairing the skin barrier function, anti-inflammation, reducing pigment synthesis, and improving microcirculation.

Today, WINONA, which has become a benchmark for dermatological skincare products in China, is aligning with international standards, continuously bringing the innovative strength of Chinese skincare products to the international stage, and continuously advancing the global development of dermatology.

Contacts

Yunnan Botanee Bio-technology Group Co., Ltd

Xinyi Liu

[email protected]